Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Jo

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Journal of the American Academy of Dermatology|January 11, 2021
Facial and neck erythema associated with dupilumab treatment: A systematic reviewChristine E Jo, Alexandra Finstad, Jorge R Georgakopoulos, et al.
The Journal of Dermatological Treatment|September 16, 2021
Topical treatment for postinflammatory hyperpigmentation: a systematic reviewMarcus G Tan, Whan B Kim, Christine E Jo, et al.
Respirology (Carlton, Vic.)|February 27, 2016
Year in review 2015: Interstitial lung disease, pulmonary vascular disease, pulmonary function, sleep and ventilation, cystic fibrosis and paediatric lung diseaseHelen E Jo, Tamera J Corte, Stephen J Wort, et al.
HSS Journal : the Musculoskeletal Journal of Hospital for Special Surgery|July 8, 2016
Evaluating the Diagnostic Yield of Computed Tomography-Guided Aspirations in Suspected Post-operative Spine InfectionsJonathan E Jo, Andy O Miller, Matthew R Cohn, et al.
Journal of Investigational Allergology & Clinical Immunology|February 20, 2025
Generalized Eczema as a Transient Paradoxical Adverse Effect of DupilumabD Betancor, M Valverde-Monge, J L Díaz-Recuero, et al.
BMC Pulmonary Medicine|February 3, 2016
Evaluating the interstitial lung disease multidisciplinary meeting: a survey of expert centresHelen E Jo, Tamera J Corte, Yuben Moodley, et al.
HSS Journal : the Musculoskeletal Journal of Hospital for Special Surgery|July 10, 2018
An Alternative Macrophage Activation Pathway Regulator, CHIT1, May Provide a Serum and Synovial Fluid Biomarker of Periprosthetic OsteolysisSamir K Trehan, Lester Zambrana, Jonathan E Jo, et al.
Journal of Cutaneous Medicine and Surgery|May 23, 2020
Short-Term Evaluation of the Real-World Efficacy and Safety of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis: A Canadian Multicenter Retrospective Cohort StudyChristine E Jo, Jorge R Georgakopoulos, Matthew Ladda, et al.
Biochimica Et Biophysica Acta|March 15, 2001
Effect of magainin, class L, and class A amphipathic peptides on fatty acid spin labels in lipid bilayersJ M Boggs, E Jo, I V Polozov, et al.
Journal of the American Academy of Dermatology|February 20, 2020
Evaluation of long-term efficacy, safety, and reasons for discontinuation of dupilumab for moderate to severe atopic dermatitis in clinical practice: A retrospective cohort studyChristine E Jo, Jorge R Georgakopoulos, Matthew Ladda, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Journal of the American Academy of Dermatology|January 11, 2021
Facial and neck erythema associated with dupilumab treatment: A systematic reviewChristine E Jo, Alexandra Finstad, Jorge R Georgakopoulos, et al.
The Journal of Dermatological Treatment|September 16, 2021
Topical treatment for postinflammatory hyperpigmentation: a systematic reviewMarcus G Tan, Whan B Kim, Christine E Jo, et al.
Respirology (Carlton, Vic.)|February 27, 2016
Year in review 2015: Interstitial lung disease, pulmonary vascular disease, pulmonary function, sleep and ventilation, cystic fibrosis and paediatric lung diseaseHelen E Jo, Tamera J Corte, Stephen J Wort, et al.
HSS Journal : the Musculoskeletal Journal of Hospital for Special Surgery|July 8, 2016
Evaluating the Diagnostic Yield of Computed Tomography-Guided Aspirations in Suspected Post-operative Spine InfectionsJonathan E Jo, Andy O Miller, Matthew R Cohn, et al.
Journal of Investigational Allergology & Clinical Immunology|February 20, 2025
Generalized Eczema as a Transient Paradoxical Adverse Effect of DupilumabD Betancor, M Valverde-Monge, J L Díaz-Recuero, et al.
BMC Pulmonary Medicine|February 3, 2016
Evaluating the interstitial lung disease multidisciplinary meeting: a survey of expert centresHelen E Jo, Tamera J Corte, Yuben Moodley, et al.
HSS Journal : the Musculoskeletal Journal of Hospital for Special Surgery|July 10, 2018
An Alternative Macrophage Activation Pathway Regulator, CHIT1, May Provide a Serum and Synovial Fluid Biomarker of Periprosthetic OsteolysisSamir K Trehan, Lester Zambrana, Jonathan E Jo, et al.
Journal of Cutaneous Medicine and Surgery|May 23, 2020
Short-Term Evaluation of the Real-World Efficacy and Safety of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis: A Canadian Multicenter Retrospective Cohort StudyChristine E Jo, Jorge R Georgakopoulos, Matthew Ladda, et al.
Biochimica Et Biophysica Acta|March 15, 2001
Effect of magainin, class L, and class A amphipathic peptides on fatty acid spin labels in lipid bilayersJ M Boggs, E Jo, I V Polozov, et al.
Journal of the American Academy of Dermatology|February 20, 2020
Evaluation of long-term efficacy, safety, and reasons for discontinuation of dupilumab for moderate to severe atopic dermatitis in clinical practice: A retrospective cohort studyChristine E Jo, Jorge R Georgakopoulos, Matthew Ladda, et al.
Pageof 6